Main research lines

- Noradrenergic dysfunction in the non-motor stages of Parkinson's disease.

- Identification of biomarkers and pharmacological interventions in the early stages of Parkinson's disease.

Brief CV

I am an associate professor of pharmacology at the UPV/EHU and a junior researcher with an emerging leadership career and consolidated expertise in the field of Parkinson's disease (PD). I earned my PhD in 2008 from the UPV/EHU, where my research focused on the role of monoaminergic systems in L-DOPA-induced dyskinesia and non-motor complications of PD, using behavioral and in vivo electrophysiological approaches in animal models.

In 2009, I joined the Institut des Maladies Neurodégénératives at the University of Bordeaux as a postdoctoral researcher in Dr. J. Baufreton’s group. My training focused on studying GABAergic synaptic transmission in the basal ganglia during parkinsonism, mastering advanced experimental techniques such as patch-clamp recordings in brain slices and optogenetics.

Throughout my career, I have held predoctoral, postdoctoral, and visiting professor positions at the University of Cádiz (Dr. JA Micó), Lund University (Dr. MA Cenci), and the University of Bordeaux (Dr. J. Baufreton and Dr. X. Leinekugel). Since 2019, I have been an associate professor at the UPV/EHU.

Currently, my research goal is to understand how monoaminergic systems contribute to the development of non-motor complications in animal models of PD. My scientific track record includes:

- Publications: 23 co-authored original articles (22 in Q1 journals), 8 reviews (5 in Q1), and 4 book chapters.

- Impact: H-index of 15 (Google Scholar).

- Supervision: Mentor of 3 PhD theses, 7 master's theses (TFM), and 11 undergraduate final projects (TFG).

- Funding: Participant in 21 research projects, serving as principal investigator (PI) in 4 of them.